Circ_0000190 directly involved in EGFR-MAPK-ERK signaling to promote NSCLC progression, emphasizing the potential of inhibiting circ_0000190 as a therapeutic strategy against NSCLC (14). This evidence concerns the gene EGFR and non-small cell lung carcinoma.